Start with what you need treated.

Proton beam therapy delivers radiation using protons rather than conventional X-rays, taking advantage of the unique physical property of protons to deposit most of their energy directly at the tumor and very little beyond it, significantly reducing radiation exposure to surrounding healthy tissue and organs. This precision makes proton therapy particularly valuable for treating tumors located near critical structures such as the brain, spinal cord, or eyes, and for treating children, where minimizing long-term radiation side effects on developing tissue is especially important. Treatment is delivered on an outpatient basis, typically over several weeks with daily sessions lasting 15 to 30 minutes each, similar in schedule to conventional radiation therapy. Each session is painless, similar to having an X-ray taken, though a customized immobilization device is used to ensure precise, consistent positioning for each treatment. Side effects are generally milder than conventional radiation due to the reduced exposure to healthy surrounding tissue, though some fatigue and localized skin or organ-specific effects can still occur. Long-term follow-up monitors treatment response and any late effects of therapy.

Cervical cancer treatment is determined primarily by the stage at diagnosis, with early-stage cancer often treated surgically, ranging from a cone biopsy or simple hysterectomy for very early disease to a radical hysterectomy with lymph node removal for slightly more advanced but still localized cancer. More advanced cervical cancer, or cases where surgery is not appropriate, is typically treated with a combination of radiation therapy and chemotherapy given concurrently, which has been shown to improve outcomes compared to radiation alone. Surgery is performed under general anesthesia, often using minimally invasive techniques for early-stage disease, while radiation and chemotherapy are typically delivered over several weeks on an outpatient basis with periodic monitoring. Regular follow-up examinations and imaging continue after treatment completion to monitor for recurrence. Cervical cancer detected at an early stage through routine screening has an excellent prognosis, highlighting the importance of regular Pap smears and HPV testing for early detection. A multidisciplinary team of gynecologic oncologists and radiation oncologists coordinates the overall treatment approach.

Keratopigmentation, sometimes called corneal tattooing, involves implanting biocompatible pigment into the layers of the cornea, either for cosmetic purposes to change the perceived eye color, or for medical reasons to camouflage a scarred or discolored cornea that affects the eye's appearance, particularly when the eye is blind or has significant scarring from prior injury or disease. Modern techniques use a laser to create precise channels or pockets within the corneal tissue for pigment placement, offering more control and safety compared to older manual methods. The procedure is performed under local anesthesia with numbing eye drops and typically takes 30 to 60 minutes. Patients experience mild discomfort and light sensitivity for a few days following the procedure, with vision typically unaffected if performed correctly and the procedure limited to the appropriate corneal layers. Given the specialized and largely elective or cosmetic nature of many applications, thorough discussion of risks and expectations with an experienced ophthalmologist is essential beforehand. Results are generally considered permanent, though some fading can occur over many years.

Breast cancer treatment is highly individualized, guided by the specific tumor type, its receptor status, stage, and the patient's overall health and preferences, typically involving a combination of surgery, which can range from breast-conserving lumpectomy to full mastectomy, and additional treatments such as radiation therapy, chemotherapy, hormonal therapy, or targeted biologic therapy depending on the cancer's specific characteristics. Surgery is performed under general anesthesia, often combined with evaluation of nearby lymph nodes to determine whether cancer has spread beyond the breast. Radiation therapy, when needed, is typically delivered over several weeks following surgery on an outpatient basis, while chemotherapy or targeted therapy may be given before surgery to shrink the tumor or after surgery to reduce recurrence risk, administered in cycles over several months. A multidisciplinary team including surgeons, medical oncologists, and radiation oncologists coordinates the overall treatment plan tailored specifically to each patient's cancer characteristics. Regular follow-up continues for years after treatment to monitor for recurrence and manage any long-term treatment effects. With modern, individualized treatment approaches, the majority of patients diagnosed with early-stage breast cancer achieve excellent long-term outcomes.

Surgical treatment of prostate cancer, or radical prostatectomy, involves complete removal of the prostate gland along with surrounding tissue and, when indicated, nearby lymph nodes, aiming to eliminate cancer that is confined to the prostate. The procedure is increasingly performed using robotic-assisted laparoscopic technique, which offers the surgeon enhanced precision and visualization through several small incisions, generally resulting in less blood loss and a faster recovery compared to traditional open surgery. The operation is performed under general anesthesia and typically takes two to four hours. A urinary catheter is required for one to two weeks after surgery while the urinary tract heals, and patients undergo pelvic floor exercises to help restore urinary control, which typically improves over several months. Depending on the surgical approach and the patient's baseline function, sexual function may also be affected and gradually improve over time, with treatment options available to support recovery. Regular PSA blood tests after surgery monitor for any signs of cancer recurrence, with most patients with localized disease achieving excellent long-term cancer control.

CAR-T cell therapy is an innovative form of immunotherapy in which a patient's own T-cells, a type of immune cell, are collected through a blood draw process similar to dialysis, then genetically engineered in a specialized laboratory to express a receptor that allows them to specifically recognize and attack cancer cells. After a period of laboratory modification and expansion taking several weeks, the engineered cells are infused back into the patient following a short course of conditioning chemotherapy designed to prepare the body to receive the modified cells. Patients require close hospital monitoring for one to two weeks following infusion, as this treatment can cause significant side effects including cytokine release syndrome and neurological symptoms that require prompt, specialized management by an experienced treatment team. This therapy is currently used primarily for certain aggressive blood cancers, including specific types of leukemia and lymphoma, that have not responded to standard treatments. Many patients who achieve a response to CAR-T therapy experience durable, long-lasting remission, representing a significant advance for previously difficult-to-treat cancers. Long-term follow-up continues to monitor for both cancer recurrence and any delayed treatment-related effects.

Stomach cancer treatment typically combines surgery with chemotherapy, with the specific approach determined by how far the cancer has spread at diagnosis, ranging from removal of only the affected portion of the stomach (subtotal gastrectomy) for more localized disease to removal of the entire stomach (total gastrectomy) for more extensive disease, along with removal of nearby lymph nodes to assess and treat potential cancer spread. Chemotherapy is frequently given both before surgery to shrink the tumor and improve the chances of complete surgical removal, and after surgery to address any remaining microscopic disease and reduce recurrence risk. Surgery is performed under general anesthesia and can take three to five hours depending on the extent of stomach removal and reconstruction required to restore digestive continuity. Following total gastrectomy, patients require significant dietary adjustments, including smaller, more frequent meals and lifelong vitamin B12 supplementation. A multidisciplinary team of surgical and medical oncologists coordinates the overall treatment plan and monitors long-term nutritional status and cancer surveillance after treatment completion.

Ovarian cancer surgery serves the dual purpose of removing as much cancer as possible while also providing crucial staging information that guides further treatment decisions, typically involving removal of both ovaries, fallopian tubes, the uterus, and often nearby lymph nodes and additional tissue where cancer may have spread within the abdomen. The extent of surgery, known as debulking or cytoreductive surgery, aims to leave behind no visible tumor when possible, since the amount of cancer removed significantly impacts how well subsequent chemotherapy works and overall prognosis. This is a major abdominal operation performed under general anesthesia, often taking four to six hours or longer depending on the extent of disease found during surgery. Most patients receive chemotherapy after surgery, and in some cases before surgery as well, to treat any remaining microscopic cancer cells throughout the abdomen. Recovery from this extensive surgery typically takes four to six weeks, with a gradual return to normal activities. Regular follow-up with blood tests, including CA-125 tumor marker monitoring, and imaging tracks for cancer recurrence over subsequent years.

Breast conservation surgery, or lumpectomy, removes only the cancerous tumor along with a margin of surrounding healthy tissue, preserving the majority of the breast, making it an appropriate option for many patients with early-stage breast cancer where the tumor is relatively small in relation to breast size. The surgeon often also removes and evaluates one or more nearby lymph nodes at the same time to check whether cancer has spread beyond the breast. The procedure is performed under general anesthesia and typically takes one to two hours. Because some cancer cells may remain undetected in the surrounding breast tissue, radiation therapy is almost always recommended after lumpectomy, delivered over several weeks on an outpatient basis, to reduce the risk of local recurrence. Numerous large studies have shown that breast conservation surgery combined with radiation therapy provides equivalent long-term survival outcomes to mastectomy for appropriately selected patients. Most patients experience good cosmetic results and recover relatively quickly, returning to normal activities within one to two weeks.

Adenocarcinoma refers to cancer that develops from glandular cells, which line many organs throughout the body, meaning treatment approach varies considerably depending on which organ is affected, whether it be the lung, colon, pancreas, prostate, or another site, along with the cancer's specific stage and molecular characteristics. Treatment planning begins with a thorough diagnostic workup, including imaging and often molecular testing of the tumor, to determine the most effective, individualized combination of surgery, chemotherapy, radiation therapy, or increasingly, targeted therapies and immunotherapy designed to attack specific features of the cancer cells. The treatment team, care setting, and expected recovery time are all specific to the organ involved and extent of disease, ranging from outpatient targeted drug therapy to major surgery requiring extended hospital stays. A multidisciplinary team of relevant specialists, coordinated by a medical oncologist, develops and oversees the individualized treatment plan for each patient. Regular follow-up monitors treatment response and watches for potential recurrence, with the overall approach continually refined based on how the specific cancer responds to treatment. Outcomes vary significantly based on the organ involved, stage at diagnosis, and specific tumor characteristics.

Adrenal cancer treatment centers on surgical removal of the affected adrenal gland (adrenalectomy), which can often be performed using minimally invasive laparoscopic techniques for smaller tumors, while larger or more locally advanced tumors typically require open surgery to ensure complete removal with clear margins, given the more aggressive nature of many adrenal cancers. Since adrenal tumors can sometimes produce excess hormones causing symptoms such as high blood pressure or metabolic changes, medication to control these hormone-related effects is often needed both before and after surgery. For cancer that has spread beyond the adrenal gland or cannot be completely removed surgically, chemotherapy and other systemic treatments are used to control disease progression. Surgery is performed under general anesthesia and duration varies based on tumor size and surgical approach. Regular follow-up with hormone level testing and imaging monitors for recurrence, which is unfortunately relatively common with this cancer type, requiring long-term surveillance. A specialized endocrine oncology team typically coordinates the complex, individualized treatment plan for this less common cancer type.

Carcinoma of unknown primary treatment begins with an extensive diagnostic workup, including detailed imaging, blood tests, and specialized pathology techniques on biopsy samples, aimed at identifying the cancer's tissue of origin as precisely as possible, since this information significantly influences treatment selection even when the exact primary site remains elusive. Modern molecular and genetic testing of the tumor tissue can often provide valuable clues about the likely origin and guide selection of the most appropriate targeted therapy, even without definitively identifying the primary site. Based on these findings, treatment typically involves chemotherapy regimens chosen to be effective against the most likely tumor types, or increasingly, targeted therapies or immunotherapy if the tumor's molecular profile suggests these approaches would be effective. Treatment is generally administered on an outpatient basis in cycles over several months, with regular imaging to monitor response. A medical oncologist experienced in this challenging diagnostic and treatment scenario typically guides the individualized treatment approach. While the outlook can be more uncertain compared to cancers with a known primary site, some patients, particularly those with more favorable tumor characteristics identified through modern testing, can achieve good treatment responses and meaningful disease control.